Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer

Overview of attention for article published in Frontiers in immunology, March 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 13 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 48,421 followers.

RT @FrontImmunol: New Research: Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer: Exosomes play a cruc…

19 Mar 2024

Reply Repost Favourite

Interesante minirevisión sobre el papel de PD-L1 exosomal derivado de tumor: una nueva perspectiva en la terapia PD-1/PD-L1 para el cáncer de pulmón. https://t.co/Dr9lqfZXWq

19 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer: Exosomes play a cruc…

19 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer: Exosomes play a cruc…

19 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.